Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cellerix ( TiGenix S.A.U. )
ClinicalTrials.gov Identifier:
NCT01663116
First received: August 5, 2011
Last updated: March 5, 2013
Last verified: February 2013